Search

Your search keyword '"Helmuth Reuter"' showing total 76 results

Search Constraints

Start Over You searched for: Author "Helmuth Reuter" Remove constraint Author: "Helmuth Reuter"
76 results on '"Helmuth Reuter"'

Search Results

1. Regeneration of Pancreatic Beta Cells by Modulation of Molecular Targets Using Plant-Derived Compounds: Pharmacological Mechanisms and Clinical Potential

2. Incident tuberculosis disease in patients receiving biologic therapies in the Western Cape, South Africa from 2007 to 2018

3. A retrospective review of calls to the Poisons Information Helpline of the Western Cape during the first 6 months of the COVID-19 pandemic in South Africa

4. Therapeutic Benefit in Rheumatoid Cachexia Illustrated Using a Novel Primary Human Triple Cell Coculture Model

5. The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis

6. The epidemiology and severity of scorpion envenoming in South Africa as managed by the Tygerberg Poisons Information Centre over a 10 year period

7. Higher SARS-CoV-2 seroprevalence in workers with lower socioeconomic status in Cape Town, South Africa.

8. Speckle tracking echocardiography in acute lupus myocarditis: comparison to conventional echocardiography

9. An overview of the biological disease modifying drugs available for arthritic conditions in South Africa

10. Review of the safety of nonsteroidal anti-inflammatory drugs and selective cyclo-oxygenase-2 inhibitors

11. Non-allopathic adjuvant management of osteoarthritis by alkalinisation of the diet

13. Psychopathology and coping in recently diagnosed HIV/AIDS patients - the role of gender

14. Lupus myocarditis: review of current diagnostic modalities and their application in clinical practice

15. Ivermectin for COVID-19: Promising but not yet conclusive

16. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

17. Pharmacokinetics of Para‐Aminosalicylic Acid and Its 2 Major Metabolites: A Potential Relationship to the Development of Gastrointestinal Intolerance

18. Drug concentration at the site of disease in children with pulmonary tuberculosis

19. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

20. An overview of analgesics: NSAIDs, paracetamol, and topical analgesics Part 1

21. The epidemiology and severity of scorpion envenoming in South Africa as managed by the Tygerberg Poisons Information Centre over a 10 year period

22. Outcome of clinical and subclinical myocardial injury in systemic lupus erythematosus - A prospective cohort study

23. Higher SARS-CoV-2 seroprevalence in workers with lower socioeconomic status in Cape Town, South Africa

24. Myocardial injury in systemic lupus erythematosus according to cardiac magnetic resonance tissue characterization: clinical and echocardiographic features

25. Serum cytokine levels associated with myocardial injury in systemic lupus erythematosus

26. The pharmacokinetics of para-aminosalicylic acid and its relationship to efficacy and intolerance

27. P607Myocardial injury in systemic lupus erythematosus defined by cardiac magnetic resonance imaging: clinical and echocardiographic characteristics

28. Critical evaluation of causality assessment of herb-drug interactions in patients

30. Speckle tracking echocardiography in acute lupus myocarditis: comparison to conventional echocardiography

31. FRI0230 CLINICAL AND ECHOCARDIOGRAPHIC CHARACTERISTICS OF MYOCARDIAL INJURY IN SYSTEMIC LUPUS ERYTHEMATOSUS, CLASSIFIED ACCORDING TO CARDIAC MAGNETIC RESONANCECRITERIA

32. Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis

33. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

34. Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa

35. Clinical features and outcome of lupus myocarditis in the Western Cape, South Africa

36. Benefit v. risk when using chloroquine in patients with severe COVID-19 disease

37. South African Marine Envenomations and Poisonings as Managed Telephonically by the Tygerberg Poisons Information Centre: A 20-Year Retrospective Review

38. Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

39. Diagnosing tuberculous pericarditis

40. Beijing and Haarlem Genotypes Are Overrepresented among Children with Drug-Resistant Tuberculosis in the Western Cape Province of South Africa

41. updAIDS in SA Family Practice

42. Characterization of the immunological features of tuberculous pericardial effusions in HIV positive and HIV negative patients in contrast with non-tuberculous effusions

43. Non-allopathic adjuvant management of osteoarthritis by alkalinisation of the diet

44. Determinants of unprotected sex among HIV-positive patients in South Africa

45. Infective endocarditis in the Western Cape Province of South Africa: a three-year prospective study

46. The Use of Adenosine Deaminase and Interferon-γ as Diagnostic Tools for Tuberculous Pericarditis

47. Role of Biochemical Tests in the Diagnosis of Large Pericardial Effusions

48. Interventions for increasing the proportion of health professionals practising in rural and other underserved areas

Catalog

Books, media, physical & digital resources